A new, completely redesigned DIDB is here!

Check out the new DIDB at https://didb.druginteractionsolutions.org

What’s new?

  • Whole new look and feel, but don’t get worried, the workflow remains unchanged. You’ll be able to jump right in.
  • New improved autocompletes to find the compound or therapeutic class you want.
  • You can now select a default compound to use in all DIDB queries.
  • New sortable and searchable query result tables.  Give these a try, you’ll like them.
  • Oh, and this all works on your tablet or phone… well, if your phone is shiny and new.

If a picture is worth a thousand words, a fully functioning website is worth a thousand pictures. Check it out https://didb.druginteractionsolutions.org.

This new version of DIDB went live on November 3rd.

If you have any questions or comments please contact us.

DIDB Team to exhibit at the 10th International ISSX Meeting – Toronto 09/29-10/03, 2013

Please visit the DIDB Team at Booth #602 during this year’s 10th International ISSX Meeting to be held in Toronto, Canada September 29 – October 3, 2013.

Also, please come to the following poster presentation:

  • P168 – Analysis of metabolism and transport drug interaction data in new drug applications approved in 2012 (Mulgaonkar A, Ragueneau-Majlessi I, Chung S, Zhang L, and Zhao P)
  • Tuesday, October 1
  • Poster Viewing: 10:30 – 14:00
  • Presented by Authors: 13:30 – 14:00 (Dr. Ragueneau-Majlessi)

DIDB program releases e-PKGene

The DIDB program has released its pharmacogenetic database, e-PKGene. For more information on e-PKgene please see the e-PKGene User Guide.

Part of the release also includes a new website where DIDB users can easily access both applications with a single login.

First, you need to register and create an individual account. To do so, use your current company login/password for the DIDB, and follow the few steps. When asked to provide your email address, please provide your WORK email.

If you have any questions regarding the release or experience any difficulty creating your new password, please contact us.